DelveInsight's Hepatocellular Carcinoma pipeline report depicts a robust space with 90+ active players working to develop 95+ pipeline therapies for Hepatocellular Carcinoma treatment.

General and Administrative (G&A) Expenses. G&A expenses for the three months ended March 31, 2025 were $6.9 million compared to $5.1 million for the same period in 2024. The increase was primarily ...

Industry Giants Gilead Sciences, Bristol Myers Squibb, AbbVie, and Merck & Co. Lead the CompetitionDublin, May 06, 2025 (GLOBE NEWSWIRE) -- The "Liver Disease Treatments Market" report has been added ...

pylori) and hepatocellular carcinoma (HCC). These tests represent an addressable market size of more than $15 billion. Currently, celiac, respiratory multiplex and H. pylori tests have CE marks ...

Senti Biosciences, Inc.’s SNTI share price has dipped by 6.26%, which has investors questioning if this is right time to buy.

Tyra Biosciences, Inc.’s TYRA share price has dipped by 5.48%, which has investors questioning if this is right time to buy.

Inari, the SEEDesigntm company, appointed long-time agriculture industry leader Lisa Nunez Safarian to its board of directors ...

We recently compiled a list of the 20 Large-Cap Stocks Insiders and Short Sellers Are Dumping Like Crazy. In this article, we ...

By analysing DNA from blood samples, Tvaster Genkalp is working to make cancer diagnostics more accessible, accurate, and ...

Westpac dragged the banks lower, oil giants slipped, but Qantas soared on cheaper fuel and XPON was up 300pc on acquisition ...

Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 125.3 million in the first quarter of 2025 (Q1 2024: NOK 116.8 million), and an EBITDA of NOK 1.8 million (7.9) for the company ...

An eighth day of gains just wasn’t to be for the ASX, with the bourse stumbling to fall about a full percentage point today ...